Latest Market Segmentation News

Neurotech International has reported excellent safety and tolerability for its lead drug NTI164 in 28-day GLP toxicology studies, paving the way for regulatory submissions and longer-term clinical development.

AdAlta Limited has announced a pro rata renounceable rights offer to raise approximately $1.29 million, aiming to fund its strategic pivot towards licensing CAR-T cell therapies through its subsidiary AdCella. The offer includes new shares and options, underpinned by key insiders and an underwriting agreement.

Forbidden Foods Limited has reported a remarkable 218% increase in April invoiced sales, driven by robust ecommerce growth and the recent integration of Oat Milk Goodness. The company is on track to surpass $4 million in annual sales, signaling strong momentum in the health and wellness FMCG sector.

Zimi Limited confirms $1.42 million in open orders with key distributor GSM Electrical, backed by shareholder approval for up to $6 million in future sales. The company also advances its commercial market ambitions through a new partnership with Zencontrol.

Flagship Minerals has secured a binding option to acquire the Pantanillo Gold Project in Chile, positioning itself for growth in oxide gold and copper amid a strategic pivot away from lithium. The company also identified new high-priority copper targets at its Rosario project.

Cardiex reports strong early sales momentum for its CONNEQT Pulse device with approximately 3,000 units sold or contracted since its mid-January launch, supported by innovative app features and operational efficiencies. Despite regulatory delays in the US pharma sector and tariff challenges, the company is positioned for scalable growth and category leadership in preventative cardiovascular care.

Adherium Limited reports a surge in US commercial patients for its Hailie Smartinhaler platform, alongside strategic hires and a new product launch compatible with AstraZeneca inhalers, underpinning plans for a capital raise.

Fluence Corporation Limited reported a robust 64.5% revenue increase in Q1 2025, driven by a strategic pivot to higher-margin Smart Product Solutions and recurring revenue streams, while maintaining its full-year guidance.

Origin Energy’s March 2025 quarterly report reveals an 11% drop in Australia Pacific LNG revenue due to lower volumes and prices, while gas sales and Octopus Energy’s customer base expand robustly. Renewables investments advance with key project milestones.

WA Kaolin Limited has ramped up production with new classifiers, achieving record sales and securing a $7 million capital raise, while expanding its footprint in the Chinese market.

LTR Pharma reports strong Q1 2025 progress with FDA pre-IND meeting success, scientific acclaim for SPONTAN’s rapid absorption, and strategic launch of ROXUS to fast-track US market entry.

VRX Limited advances its Arrowsmith and North silica sand projects with a positive EPA assessment and non-binding offtake agreements totaling 440,000 tonnes annually across Asia. Despite an ongoing appeal, the company is progressing toward final approvals and project financing.